United States Urological Cancer Therapeutics Drugs Market Report 2017

Publisher Name :
Date: 13-Feb-2017
No. of pages: 116
Inquire Before Buying

Notes:

Sales, means the sales volume of Urological Cancer Therapeutics Drugs

Revenue, means the sales value of Urological Cancer Therapeutics Drugs

This report studies sales (consumption) of Urological Cancer Therapeutics Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

- Novartis

- Pfizer

- Johnson & Johnson

- AstraZeneca

- Astellas

- Bristol-Myers Squibb

- Abbott Laboratories

- Celgene Corporation

- Dendreon Corporation

- Ferring Pharmaceuticals

- GlaxoSmithKline plc

- Indevus Pharmaceuticals Inc

- Ipsen

- Roche Healthcare

- Sanofi S.A.

Market Segment by States, covering

- California

- Texas

- New York

- Florida

- Illinois

Split by product Types, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Xofigo (radium Ra 223 dichloride)

- Jevtana (cabazitaxel)

- Inlyta (axitinib)

- Votrient (pazopanib hydrochloride)

- Sutent (sunitinib malate)

- Zytiga (abiraterone acetate)

- Xtandi (enzalutamide)

- Opdivo (nivolumab)

- Provenge (sipuleucel-T)

Split by applications, this report focuses on sales, market share and growth rate of Urological Cancer Therapeutics Drugs in each application, can be divided into

- Hospital

- Medical Research Laboratory

- Others

United States Urological Cancer Therapeutics Drugs Market Report 2017

Table of Contents
United States Urological Cancer Therapeutics Drugs Market Report 2017
1 Urological Cancer Therapeutics Drugs Overview
1.1 Product Overview and Scope of Urological Cancer Therapeutics Drugs
1.2 Classification of Urological Cancer Therapeutics Drugs
1.2.1 Xofigo (radium Ra 223 dichloride)
1.2.2 Jevtana (cabazitaxel)
1.2.3 Inlyta (axitinib)
1.2.4 Votrient (pazopanib hydrochloride)
1.2.5 Sutent (sunitinib malate)
1.2.6 Zytiga (abiraterone acetate)
1.2.7 Xtandi (enzalutamide)
1.2.8 Opdivo (nivolumab)
1.2.9 Provenge (sipuleucel-T)
1.3 Application of Urological Cancer Therapeutics Drugs
1.3.1 Hospital
1.3.2 Medical Research Laboratory
1.3.3 Others
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Urological Cancer Therapeutics Drugs (2012-2022)
1.4.1 United States Urological Cancer Therapeutics Drugs Sales and Growth Rate (2012-2022)
1.4.2 United States Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2012-2022)
2 United States Urological Cancer Therapeutics Drugs Competition by Manufacturers
2.1 United States Urological Cancer Therapeutics Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Urological Cancer Therapeutics Drugs Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Urological Cancer Therapeutics Drugs Average Price by Manufactures (2015 and 2016)
2.4 Urological Cancer Therapeutics Drugs Market Competitive Situation and Trends
2.4.1 Urological Cancer Therapeutics Drugs Market Concentration Rate
2.4.2 Urological Cancer Therapeutics Drugs Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 United States Urological Cancer Therapeutics Drugs Sales (Volume) and Revenue (Value) by States (2012-2017)
3.1 United States Urological Cancer Therapeutics Drugs Sales and Market Share by States (2012-2017)
3.2 United States Urological Cancer Therapeutics Drugs Revenue and Market Share by States (2012-2017)
3.3 United States Urological Cancer Therapeutics Drugs Price by States (2012-2017)
4 United States Urological Cancer Therapeutics Drugs Sales (Volume) and Revenue (Value) by Type (2012-2017)
4.1 United States Urological Cancer Therapeutics Drugs Sales and Market Share by Type (2012-2017)
4.2 United States Urological Cancer Therapeutics Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States Urological Cancer Therapeutics Drugs Price by Type (2012-2017)
4.4 United States Urological Cancer Therapeutics Drugs Sales Growth Rate by Type (2012-2017)
5 United States Urological Cancer Therapeutics Drugs Sales (Volume) by Application (2012-2017)
5.1 United States Urological Cancer Therapeutics Drugs Sales and Market Share by Application (2012-2017)
5.2 United States Urological Cancer Therapeutics Drugs Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
6 United States Urological Cancer Therapeutics Drugs Manufacturers Profiles/Analysis
6.1 Novartis
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Urological Cancer Therapeutics Drugs Product Type, Application and Specification
6.1.2.1 Xofigo (radium Ra 223 dichloride)
6.1.2.2 Jevtana (cabazitaxel)
6.1.3 Novartis Urological Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Pfizer
6.2.2 Urological Cancer Therapeutics Drugs Product Type, Application and Specification
6.2.2.1 Xofigo (radium Ra 223 dichloride)
6.2.2.2 Jevtana (cabazitaxel)
6.2.3 Pfizer Urological Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Johnson & Johnson
6.3.2 Urological Cancer Therapeutics Drugs Product Type, Application and Specification
6.3.2.1 Xofigo (radium Ra 223 dichloride)
6.3.2.2 Jevtana (cabazitaxel)
6.3.3 Johnson & Johnson Urological Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 AstraZeneca
6.4.2 Urological Cancer Therapeutics Drugs Product Type, Application and Specification
6.4.2.1 Xofigo (radium Ra 223 dichloride)
6.4.2.2 Jevtana (cabazitaxel)
6.4.3 AstraZeneca Urological Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Astellas
6.5.2 Urological Cancer Therapeutics Drugs Product Type, Application and Specification
6.5.2.1 Xofigo (radium Ra 223 dichloride)
6.5.2.2 Jevtana (cabazitaxel)
6.5.3 Astellas Urological Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Bristol-Myers Squibb
6.6.2 Urological Cancer Therapeutics Drugs Product Type, Application and Specification
6.6.2.1 Xofigo (radium Ra 223 dichloride)
6.6.2.2 Jevtana (cabazitaxel)
6.6.3 Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Abbott Laboratories
6.7.2 Urological Cancer Therapeutics Drugs Product Type, Application and Specification
6.7.2.1 Xofigo (radium Ra 223 dichloride)
6.7.2.2 Jevtana (cabazitaxel)
6.7.3 Abbott Laboratories Urological Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Celgene Corporation
6.8.2 Urological Cancer Therapeutics Drugs Product Type, Application and Specification
6.8.2.1 Xofigo (radium Ra 223 dichloride)
6.8.2.2 Jevtana (cabazitaxel)
6.8.3 Celgene Corporation Urological Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Dendreon Corporation
6.9.2 Urological Cancer Therapeutics Drugs Product Type, Application and Specification
6.9.2.1 Xofigo (radium Ra 223 dichloride)
6.9.2.2 Jevtana (cabazitaxel)
6.9.3 Dendreon Corporation Urological Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Ferring Pharmaceuticals
6.10.2 Urological Cancer Therapeutics Drugs Product Type, Application and Specification
6.10.2.1 Xofigo (radium Ra 223 dichloride)
6.10.2.2 Jevtana (cabazitaxel)
6.10.3 Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 GlaxoSmithKline plc
6.12 Indevus Pharmaceuticals Inc
6.13 Ipsen
6.14 Roche Healthcare
6.15 Sanofi S.A.
7 Urological Cancer Therapeutics Drugs Manufacturing Cost Analysis
7.1 Urological Cancer Therapeutics Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Urological Cancer Therapeutics Drugs
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Urological Cancer Therapeutics Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Urological Cancer Therapeutics Drugs Major Manufacturers in 2015
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 United States Urological Cancer Therapeutics Drugs Market Forecast (2017-2022)
11.1 United States Urological Cancer Therapeutics Drugs Sales, Revenue Forecast (2017-2022)
11.2 United States Urological Cancer Therapeutics Drugs Sales Forecast by Type (2017-2022)
11.3 United States Urological Cancer Therapeutics Drugs Sales Forecast by Application (2017-2022)
11.4 Urological Cancer Therapeutics Drugs Price Forecast (2017-2022)
12 Research Findings and Conclusion
13 Appendix
Methodology
Analyst Introduction
Data Source
List of Tables and Figures
Figure Picture of Urological Cancer Therapeutics Drugs
Table Classification of Urological Cancer Therapeutics Drugs
Figure United States Sales Market Share of Urological Cancer Therapeutics Drugs by Type in 2015
Figure Xofigo (radium Ra 223 dichloride) Picture
Figure Jevtana (cabazitaxel) Picture
Figure Inlyta (axitinib) Picture
Figure Votrient (pazopanib hydrochloride) Picture
Figure Sutent (sunitinib malate) Picture
Figure Zytiga (abiraterone acetate) Picture
Figure Xtandi (enzalutamide) Picture
Figure Opdivo (nivolumab) Picture
Figure Provenge (sipuleucel-T) Picture
Table Application of Urological Cancer Therapeutics Drugs
Figure United States Sales Market Share of Urological Cancer Therapeutics Drugs by Application in 2015
Figure Hospital Examples
Figure Medical Research Laboratory Examples
Figure Others Examples
Figure United States Urological Cancer Therapeutics Drugs Sales and Growth Rate (2012-2022)
Figure United States Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2012-2022)
Table United States Urological Cancer Therapeutics Drugs Sales of Key Manufacturers (2015 and 2016)
Table United States Urological Cancer Therapeutics Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Urological Cancer Therapeutics Drugs Sales Share by Manufacturers
Figure 2016 Urological Cancer Therapeutics Drugs Sales Share by Manufacturers
Table United States Urological Cancer Therapeutics Drugs Revenue by Manufacturers (2015 and 2016)
Table United States Urological Cancer Therapeutics Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Urological Cancer Therapeutics Drugs Revenue Share by Manufacturers
Table 2016 United States Urological Cancer Therapeutics Drugs Revenue Share by Manufacturers
Table United States Market Urological Cancer Therapeutics Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Urological Cancer Therapeutics Drugs Average Price of Key Manufacturers in 2015
Figure Urological Cancer Therapeutics Drugs Market Share of Top 3 Manufacturers
Figure Urological Cancer Therapeutics Drugs Market Share of Top 5 Manufacturers
Table United States Urological Cancer Therapeutics Drugs Sales by States (2012-2017)
Table United States Urological Cancer Therapeutics Drugs Sales Share by States (2012-2017)
Figure United States Urological Cancer Therapeutics Drugs Sales Market Share by States in 2015
Table United States Urological Cancer Therapeutics Drugs Revenue and Market Share by States (2012-2017)
Table United States Urological Cancer Therapeutics Drugs Revenue Share by States (2012-2017)
Figure Revenue Market Share of Urological Cancer Therapeutics Drugs by States (2012-2017)
Table United States Urological Cancer Therapeutics Drugs Price by States (2012-2017)
Table United States Urological Cancer Therapeutics Drugs Sales by Type (2012-2017)
Table United States Urological Cancer Therapeutics Drugs Sales Share by Type (2012-2017)
Figure United States Urological Cancer Therapeutics Drugs Sales Market Share by Type in 2015
Table United States Urological Cancer Therapeutics Drugs Revenue and Market Share by Type (2012-2017)
Table United States Urological Cancer Therapeutics Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Urological Cancer Therapeutics Drugs by Type (2012-2017)
Table United States Urological Cancer Therapeutics Drugs Price by Type (2012-2017)
Figure United States Urological Cancer Therapeutics Drugs Sales Growth Rate by Type (2012-2017)
Table United States Urological Cancer Therapeutics Drugs Sales by Application (2012-2017)
Table United States Urological Cancer Therapeutics Drugs Sales Market Share by Application (2012-2017)
Figure United States Urological Cancer Therapeutics Drugs Sales Market Share by Application in 2015
Table United States Urological Cancer Therapeutics Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Urological Cancer Therapeutics Drugs Sales Growth Rate by Application (2012-2017)
Table Novartis Basic Information List
Table Novartis Urological Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis Urological Cancer Therapeutics Drugs Sales Market Share (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Urological Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Urological Cancer Therapeutics Drugs Sales Market Share (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Urological Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Johnson & Johnson Urological Cancer Therapeutics Drugs Sales Market Share (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Urological Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table AstraZeneca Urological Cancer Therapeutics Drugs Sales Market Share (2012-2017)
Table Astellas Basic Information List
Table Astellas Urological Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Astellas Urological Cancer Therapeutics Drugs Sales Market Share (2012-2017)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Sales Market Share (2012-2017)
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories Urological Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Abbott Laboratories Urological Cancer Therapeutics Drugs Sales Market Share (2012-2017)
Table Celgene Corporation Basic Information List
Table Celgene Corporation Urological Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Celgene Corporation Urological Cancer Therapeutics Drugs Sales Market Share (2012-2017)
Table Dendreon Corporation Basic Information List
Table Dendreon Corporation Urological Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Dendreon Corporation Urological Cancer Therapeutics Drugs Sales Market Share (2012-2017)
Table Ferring Pharmaceuticals Basic Information List
Table Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Sales Market Share (2012-2017)
Table GlaxoSmithKline plc Basic Information List
Table Indevus Pharmaceuticals Inc Basic Information List
Table Ipsen Basic Information List
Table Roche Healthcare Basic Information List
Table Sanofi S.A. Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Urological Cancer Therapeutics Drugs
Figure Manufacturing Process Analysis of Urological Cancer Therapeutics Drugs
Figure Urological Cancer Therapeutics Drugs Industrial Chain Analysis
Table Raw Materials Sources of Urological Cancer Therapeutics Drugs Major Manufacturers in 2015
Table Major Buyers of Urological Cancer Therapeutics Drugs
Table Distributors/Traders List
Figure United States Urological Cancer Therapeutics Drugs Production and Growth Rate Forecast (2017-2022)
Figure United States Urological Cancer Therapeutics Drugs Revenue and Growth Rate Forecast (2017-2022)
Table United States Urological Cancer Therapeutics Drugs Production Forecast by Type (2017-2022)
Table United States Urological Cancer Therapeutics Drugs Consumption Forecast by Application (2017-2022)
Table United States Urological Cancer Therapeutics Drugs Sales Forecast by States (2017-2022)
Table United States Urological Cancer Therapeutics Drugs Sales Share Forecast by States (2017-2022)
  • Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Liquid Chromatography Detectors Market 2018 Forecast to 2023
    Published: 15-May-2018        Price: US 4880 Onwards        Pages: 109
    Liquid Chromatography Detectors is a device used in liquid chromatography (LC) to detect components of the mixture being eluted off the chromatography column. A broad range of detectors is available to meet different sample requirements. Specific detectors respond to a particular compound only and the response is independent of mobile phase composition. On the other hand the response of bulk property detectors is dependent on collective changes in composition of sample and mobile phase. ......
  • Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) IV Bags Market 2018 Forecast to 2023
    Published: 15-May-2018        Price: US 4880 Onwards        Pages: 103
    This report studies the IV Bag market including flex plastics bag, semi-rigid IV Bags, glass bottles. Scope of the Report: This report focuses on the IV Bags in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manufacturers, this report covers - Baxter - SSY Group - ......
  • Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Fractional Flow Reserve Market 2018 Forecast to 2023
    Published: 15-May-2018        Price: US 4880 Onwards        Pages: 107
    Fractional flow reserve (FFR) is a technique used in coronary catheterization to measure pressure differences across a coronary artery stenosis (narrowing, usually due to atherosclerosis) to determine the likelihood that the stenosis impedes oxygen delivery to the heart muscle (myocardial ischemia). Scope of the Report: This report focuses on the Fractional Flow Reserve in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle Eas......
  • Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) ICAD (Intracranial Atherosclerotic Disease) Pathology Market 2018 Forecast to 2023
    Published: 15-May-2018        Price: US 4880 Onwards        Pages: 107
    Intracranial atherosclerotic disease is the progressive narrowing of the cerebral arteries within the skull (intracranial). The arteries that supply oxygen-enriched blood to the brain are the carotid arteries and the vertebral arteries. The circle of Willis is the area at the base of the brain that joins these arteries. Scope of the Report: This report focuses on the ICAD (Intracranial Atherosclerotic Disease) Pathology in Global market, especially in North America,......
  • North America and Europe APAC Hydrocolloid Market by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 04-May-2018        Price: US 4480 Onwards        Pages: 105
    A hydrocolloid dressing is an opaque or transparent dressing for wounds. A hydrocolloid dressing is biodegradeable, non-breathable, and adheres to the skin, so no separate taping is needed. Scope of the Report: This report focuses on the APAC Hydrocolloid in North America and Europe market, especially in United States, United Kingdom, Canada, Germany, France, Italy and Spain. This report categorizes the market based on manufacturers, countries/Regions, type and appl......
  • North America and Europe APAC Silver Dressing Market by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 04-May-2018        Price: US 4480 Onwards        Pages: 103
    Silver dressings are a relatively new family of advanced wound care dressings for the treatment of infected wounds. A silver dressing is a wound dressing impregnated with ionic silver. The ionic silver is responsible for the anti-microbial activity against infection caused by bacteria. Scope of the Report: This report focuses on the APAC Silver Dressing in North America and Europe market, especially in United States, United Kingdom, Canada, Germany, France, Italy an......
  • North America and Europe Breast Lesion Localization Methods Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 04-May-2018        Price: US 4480 Onwards        Pages: 109
    This report studies the Breast Lesion Localization Methods market, including wire localization biopsy, radioisotope localization, magnetic tracer and other products. Scope of the Report: This report focuses on the Breast Lesion Localization Methods in North America and Europe market, especially in United States, United Kingdom, Canada, Germany, France, Italy and Spain. This report categorizes the market based on manufacturers, countries/Regions, type and application......
  • North America and Europe Casting and Splinting Products Market by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 04-May-2018        Price: US 4480 Onwards        Pages: 105
    An orthopedic cast, or simply cast, is a shell, frequently made from plaster or fiberglass, encasing a limb (or, in some cases, large portions of the body) to stabilize and hold anatomical structures, most often a broken bone (or bones), in place until healing is confirmed. It is similar in function to a splint. Scope of the Report: This report focuses on the Casting and Splinting Products in North America and Europe market, especially in United States, United Kingd......
  • Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Oncolytic Virus Therapy Market 2018 Forecast to 2023
    Published: 27-Apr-2018        Price: US 4880 Onwards        Pages: 108
    Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn't until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs